Terms: = Gastric cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
2121 results:
1. A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
Wu Y; Zhu M; Sun B; Chen Y; Huang Y; Gai J; Li G; Li Y; Wan Y; Ma L
J Nanobiotechnology; 2024 May; 22(1):256. PubMed ID: 38755613
[TBL] [Abstract] [Full Text] [Related]
2. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
Qin W; Li J; Gao N; Kong X; Guo L; Chen Y; Huang L; Chen X; Qi F
Mol Cancer; 2024 May; 23(1):99. PubMed ID: 38730464
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer.
Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM
Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535
[TBL] [Abstract] [Full Text] [Related]
4. Critical roles of long noncoding RNA H19 in cancer.
Darmadi D; Chugaeva UY; Saleh RO; Hjazi A; Saleem HM; Ghildiyal P; Alwaily ER; Alawadi A; Alnajar MJ; Ihsan A
Cell Biochem Funct; 2024 Apr; 42(3):e4018. PubMed ID: 38644608
[TBL] [Abstract] [Full Text] [Related]
5. RAC1-mediated integrin alpha-6 expression in E-cadherin-deficient gastric cancer cells promotes interactions with the stroma and peritoneal dissemination.
Zhang J; Fu L; Wang H; Yonemura A; Semba T; Yasuda-Yoshihara N; Nishimura A; Tajiri T; Tong Y; Yasuda T; Uchihara T; Yamazaki M; Okamoto Y; Yamasaki J; Nagano O; Baba H; Ishimoto T
Cancer Lett; 2024 Jun; 591():216901. PubMed ID: 38641311
[TBL] [Abstract] [Full Text] [Related]
6. MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.
Zhang Y; Lin W; Yang Y; Zhu S; Chen Y; Wang H; Teng L
Cancer Lett; 2024 Jun; 591():216878. PubMed ID: 38609001
[TBL] [Abstract] [Full Text] [Related]
7. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
Zhong Q; Hong W; Xiong L
Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive analysis of the prognostic value and immunological role of IDO1 gene in pan-cancer.
Lin K; Wang Y; Liu F; You T; Liu X; Liu R; Li Z; Zhen C; Zhang Y; Liu X; Cai H
Eur J Med Res; 2024 Mar; 29(1):206. PubMed ID: 38539263
[TBL] [Abstract] [Full Text] [Related]
9.
Chen G; Shang J; Feng X; Li M; Zhang H; Liu J; Xu H
Anticancer Res; 2024 Apr; 44(4):1475-1485. PubMed ID: 38537964
[TBL] [Abstract] [Full Text] [Related]
10. Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer.
Zhang K; Xu Y; Chang X; Xu C; Xue W; Ding D; Nie M; Cai H; Xu J; Zhan L; Han J; Cai T; Ju D; Feng L; Zhang X; Yin K
Cancer Immunol Immunother; 2024 Mar; 73(4):75. PubMed ID: 38532108
[TBL] [Abstract] [Full Text] [Related]
11. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract] [Full Text] [Related]
12. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer.
Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y
PeerJ; 2024; 12():e17130. PubMed ID: 38515458
[TBL] [Abstract] [Full Text] [Related]
13. Identification roles of NFE2L3 in digestive system cancers.
Li F; Wen Z
J Cancer Res Clin Oncol; 2024 Mar; 150(3):150. PubMed ID: 38514488
[TBL] [Abstract] [Full Text] [Related]
14. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
15. cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis.
Li D; Huang P; Xia L; Leng W; Qin S
Int Immunopharmacol; 2024 Apr; 131():111836. PubMed ID: 38479160
[TBL] [Abstract] [Full Text] [Related]
16. H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis.
Zhao Y; Jiang J; Zhou P; Deng K; Liu Z; Yang M; Yang X; Li J; Li R; Xia J
Biochem Pharmacol; 2024 Apr; 222():116120. PubMed ID: 38461905
[TBL] [Abstract] [Full Text] [Related]
17. Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies.
Arimori T; Mihara E; Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Takagi J; Kato Y
Structure; 2024 May; 32(5):536-549.e5. PubMed ID: 38460519
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract] [Full Text] [Related]
19. HER2 targeted therapy in colorectal cancer: Current landscape and future directions.
Chen N; He L; Zou Q; Deng H
Biochem Pharmacol; 2024 May; 223():116101. PubMed ID: 38442793
[TBL] [Abstract] [Full Text] [Related]
20. Hsa_circ_0003356 suppresses gastric cancer progression via miR-556-5p/FKBP5 axis.
Lu C; Wu J; Li X; Huang W; Fang Y; Huang Y
Toxicol In Vitro; 2024 May; 97():105787. PubMed ID: 38401744
[TBL] [Abstract] [Full Text] [Related]
[Next]